Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries

Koki Nakamura1, Sharif Al-Ruzzeh, Adrian H Chester

  • 1National Heart and Lung Institute, Heart Science Centre, Harefield Hospital, Middlesex, United Kingdom.

Insights

Statins like cerivastatin preserve arterial function after coronary bypass surgery. This study shows statins protect radial artery function over time, improving vasodilation.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Vascular Biology

Background:

  • Statins may improve vascular function beyond cholesterol reduction.
  • Investigating statins' effect on coronary artery bypass graft vascular recovery.

Purpose of the Study:

  • To assess statin modulation of vascular recovery in coronary bypass graft arteries.
  • To determine if cerivastatin preserves endothelial function in radial and internal thoracic arteries.

Main Methods:

  • Radial artery and left internal thoracic artery specimens collected during coronary artery bypass grafting.
  • Vascular rings incubated with or without cerivastatin (10(-6) mol/L) for 2 or 24 hours.
  • Endothelial function assessed via organ bath technique using acetylcholine after endothelin-1 contraction.

Main Results:

  • Radial artery: Cerivastatin preserved endothelium-dependent vasodilation at 24 hours (68.4% +/- 5.0%) compared to controls (39.4% +/- 4.7%, p < 0.01).
  • Left internal thoracic artery: No significant difference in vasodilation between cerivastatin and control groups at 2 or 24 hours.
  • Time-dependent endothelial dysfunction observed in control radial arteries, but not in cerivastatin-treated arteries.

Conclusions:

  • Cerivastatin significantly preserves endothelium-dependent vasodilation in radial arteries over time.
  • Statins may play a crucial role in maintaining graft patency and function in coronary artery bypass grafting.
  • Findings suggest potential clinical benefits of statins in enhancing coronary artery bypass graft outcomes.
Abstract

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...